US pledges $2.1 billion to Glaxo, Sanofi for coronavirus vaccine - MSN Money

According to Glaxo, more than half of the $2.1 billion from the government will support further development of the vaccine, including clinical trials.

In May, French officials said it would be “unacceptable” for Americans to get first dibs on a coronavirus vaccine developed by Sanofi, a French company, after CEO Paul Hudson said that the drug company would likely provide its vaccine to the U.S.

had reached a $1.95 billion deal with them for an initial order of 100 million doses of their coronavirus vaccine, which is now on phase three of its trial.